0% found this document useful (0 votes)
63 views1 page

COVID-19 Clinical Tips for Providers

The document provides 10 clinical tips for healthcare providers on COVID-19, including that non-respiratory symptoms can appear before fever and cough, children may present similarly to adults, CT scans should not be used for screening and the potential for rapid deterioration in some patients one week after onset. It also notes coinfections with other viruses are possible and decisions on antibiotics for bacterial pneumonia should consider likelihood, severity and stewardship. Lymphopenia and elevated markers may be associated with greater severity.

Uploaded by

bezirksvor
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
63 views1 page

COVID-19 Clinical Tips for Providers

The document provides 10 clinical tips for healthcare providers on COVID-19, including that non-respiratory symptoms can appear before fever and cough, children may present similarly to adults, CT scans should not be used for screening and the potential for rapid deterioration in some patients one week after onset. It also notes coinfections with other viruses are possible and decisions on antibiotics for bacterial pneumonia should consider likelihood, severity and stewardship. Lymphopenia and elevated markers may be associated with greater severity.

Uploaded by

bezirksvor
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Ten Clinical Tips on COVID-19

for Healthcare Providers Involved in Patient Care


Accessible link: [Link]

Treatment and Prophylaxis


1. The National Institutes of Health has developed guidance on treatment
([Link] which will be regularly
updated as new evidence on the safety and efficacy of drugs and
therapeutics emerges from clinical trials and research publications.

2. There is currently no FDA-approved post-exposure prophylaxis for


people who may have been exposed to COVID-19 ([Link]
coronavirus/2019-ncov/hcp/[Link]).

Symptoms and Diagnosis


3. Non-respiratory symptoms ([Link]
[Link]) of COVID-19 – such as gastrointestinal (e.g., nausea, diarrhea) or
neurologic symptoms (e.g., anosmia, ageusia, headache) – might appear before fever and lower
respiratory tract symptoms (e.g., cough and shortness of breath).

4. Children ([Link] with COVID-19


may have fever and cough at symptom onset as often as adult patients. Although most children
with COVID-19 have not had severe illness, clinicians should maintain a high index of suspicion for
SARS-CoV-2 infection in children, particularly infants and children with underlying conditions.

5. CT scans ([Link] should not be used to screen


for COVID-19 or as a first-line test to diagnose COVID-19. CT should be used sparingly, reserved for
hospitalized, symptomatic patients with specific clinical indications for CT ([Link]
Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-
and-CT-for-Suspected-COVID19-Infection).

Coinfections
6. Patients can be infected with more than one virus at the same time. Coinfections with other
respiratory viruses ([Link] in people with
COVID-19 have been reported. Therefore, identifying infection with one respiratory virus does not
exclude SARS-CoV-2 virus infection.

7. Several patients with COVID-19 have been reported presenting with concurrent community-acquired
bacterial pneumonia ([Link] Decisions
to administer antibiotics to COVID-19 patients should be based on the likelihood of bacterial infection
(community-acquired or hospital-acquired), illness severity, and antimicrobial stewardship issues
([Link]

Severe Illness
8. Clinicians should be aware of the potential for some patients to rapidly deteriorate ([Link]
coronavirus/2019-ncov/hcp/[Link]) one week after illness onset.

9. The median time to acute respiratory distress syndrome (ARDS) ranges from 8 to 12 days ([Link]
[Link]/coronavirus/2019-ncov/hcp/[Link]).

10. Lymphopenia, neutrophilia, elevated serum alanine aminotransferase and aspartate aminotransferase
levels, elevated lactate dehydrogenase, high CRP, and high ferritin levels may be associated with greater
illness severity ([Link]
[Link]).

[Link]/coronavirus
CS 316791-A 04/30/2020

You might also like